International Stem Cell (ISCO) Other Non-Current Liabilities (2013 - 2020)
International Stem Cell (ISCO) reported Other Non-Current Liabilities of $40,000 for Q3 2020, down 87.6% from the prior quarter.
Powered by 
Analysis
International Stem Cell (ISCO) Other Non-Current Liabilities (2013 - 2020) Analysis & Trends
At the end of FY2019, International Stem Cell posted Other Non-Current Liabilities of $207,000, up 13.7% from FY2018.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -45.3% (FY2014 to FY2019).
- By year, Other Non-Current Liabilities came in at $182,000 in FY2018 (-94.2%), $3.11 million in FY2017 (+52.2%), $2.05 million in FY2016 (+755.6%) and $239,000 in FY2015 (-94.3%).
- The Q3 2020 figure ranks as the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2013.
- Year over year, Other Non-Current Liabilities gained in 1 of the last six quarters, with an average decline of 60.3%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2016 (growth of 755.6%); the low point was Q4 2015 (a decline of 94.3%).
- Per Business Quant data, the three quarters before Q3 2020 came in at $322,000 (Q2 2020), $97,000 (Q1 2020) and $207,000 (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.11 Bn | 534.64 Bn | 17.26 Bn |
| 3 | AbbVie | 501.21 Bn | 474.32 Bn | 12.70 Bn |
| 4 | Merck | 367.51 Bn | 321.89 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.95 Bn | 261.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn |
| 7 | Amgen | 235.88 Bn | 191.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.74 Bn | 164.94 Bn | 6.22 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn |
| 10 | International Stem Cell | 1.68 Mn | -2.29 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 40,000.00 |
| Jun 30, 2020 | 322,000.00 |
| Mar 31, 2020 | 97,000.00 |
| Dec 31, 2019 | 207,000.00 |
| Jun 30, 2019 | 837,000.00 |
| Mar 31, 2019 | 1.15 Mn |
| Dec 31, 2018 | 182,000.00 |
| Sep 30, 2018 | 2.02 Mn |
| Jun 30, 2018 | 2.78 Mn |
| Mar 31, 2018 | 2.76 Mn |
| Dec 31, 2017 | 3.11 Mn |
| Sep 30, 2017 | 3.67 Mn |
| Jun 30, 2017 | 2.49 Mn |
| Mar 31, 2017 | 4.08 Mn |
| Dec 31, 2016 | 2.05 Mn |
| Sep 30, 2016 | 5.42 Mn |
| Jun 30, 2016 | 7.15 Mn |
| Mar 31, 2016 | 19.62 Mn |
| Dec 31, 2015 | 239,000.00 |
| Sep 30, 2015 | 1.35 Mn |
API Access
International Stem Cell Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();